Blomme EA[au] - Search Results

Year	Number of Results
1998	7
1999	6
2000	1
2001	4
2002	2
2003	9
2004	3
2005	2
2006	3
2007	6
2008	11
2009	5
2010	6
2011	5
2012	4
2013	2
2014	1
2015	3
2016	3
2017	3
2018	2
2019	3
2020	1
2021	1
2022	0

1

Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models.

Weaver RJ, Blomme EA, Chadwick AE, Copple IM, Gerets HHJ, Goldring CE, Guillouzo A, Hewitt PG, Ingelman-Sundberg M, Jensen KG, Juhila S, Klingmüller U, Labbe G, Liguori MJ, Lovatt CA, Morgan P, Naisbitt DJ, Pieters RHH, Snoeys J, van de Water B, Williams DP, Park BK. Weaver RJ, et al. Among authors: blomme ea. Nat Rev Drug Discov. 2020 Feb;19(2):131-148. doi: 10.1038/s41573-019-0048-x. Epub 2019 Nov 20. Nat Rev Drug Discov. 2020. PMID: 31748707 Free article. Review.

2

Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts.

Duan WR, Garner DS, Williams SD, Funckes-Shippy CL, Spath IS, Blomme EA. Duan WR, et al. Among authors: blomme ea. J Pathol. 2003 Feb;199(2):221-8. doi: 10.1002/path.1289. J Pathol. 2003. PMID: 12533835

3

Acyl glucuronide metabolites: Implications for drug safety assessment.

Van Vleet TR, Liu H, Lee A, Blomme EAG. Van Vleet TR, et al. Among authors: blomme eag. Toxicol Lett. 2017 Apr 15;272:1-7. doi: 10.1016/j.toxlet.2017.03.003. Epub 2017 Mar 7. Toxicol Lett. 2017. PMID: 28286018 Review.

4

Toxicology Strategies for Drug Discovery: Present and Future.

Blomme EA, Will Y. Blomme EA, et al. Chem Res Toxicol. 2016 Apr 18;29(4):473-504. doi: 10.1021/acs.chemrestox.5b00407. Epub 2015 Dec 4. Chem Res Toxicol. 2016. PMID: 26588328 Review.

5

Potential functional and pathological side effects related to off-target pharmacological activity.

Lynch JJ 3rd, Van Vleet TR, Mittelstadt SW, Blomme EAG. Lynch JJ 3rd, et al. Among authors: blomme eag. J Pharmacol Toxicol Methods. 2017 Sep;87:108-126. doi: 10.1016/j.vascn.2017.02.020. Epub 2017 Feb 16. J Pharmacol Toxicol Methods. 2017. PMID: 28216264 Review.

6

Theranostics in veterinary medicine: where are we heading?

Blomme EA, Spear BB. Blomme EA, et al. Vet J. 2010 Sep;185(3):237-8. doi: 10.1016/j.tvjl.2009.09.021. Epub 2009 Nov 1. Vet J. 2010. PMID: 19884025 No abstract available.

7

Veterinary oncology: Translating research advances into innovative therapeutic and diagnostic options.

Blomme EA. Blomme EA. Vet J. 2015 Aug;205(2):117-9. doi: 10.1016/j.tvjl.2015.06.005. Epub 2015 Jun 8. Vet J. 2015. PMID: 26095035 No abstract available.

8

Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury.

Weaver RJ, Betts C, Blomme EAG, Gerets HHJ, Gjervig Jensen K, Hewitt PG, Juhila S, Labbe G, Liguori MJ, Mesens N, Ogese MO, Persson M, Snoeys J, Stevens JL, Walker T, Park BK. Weaver RJ, et al. Among authors: blomme eag. Expert Opin Drug Metab Toxicol. 2017 Jul;13(7):767-782. doi: 10.1080/17425255.2017.1341489. Epub 2017 Jun 28. Expert Opin Drug Metab Toxicol. 2017. PMID: 28604124 Review.

9

Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.

Blomme EA, Yang Y, Waring JF. Blomme EA, et al. Toxicol Lett. 2009 Apr 10;186(1):22-31. doi: 10.1016/j.toxlet.2008.09.017. Epub 2008 Oct 17. Toxicol Lett. 2009. PMID: 18996174 Review.

10

Targeted drug delivery in oncology: where drug discovery meets physics.

Hooker BA, Blomme EA. Hooker BA, et al. Among authors: blomme ea. Vet J. 2015 Aug;205(2):120-1. doi: 10.1016/j.tvjl.2015.04.034. Epub 2015 May 8. Vet J. 2015. PMID: 26021890 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results